Please use this identifier to cite or link to this item:
Title: Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes
Authors: Sandes, Alex Freire [UNIFESP]
Kerbauy, Daniela Márcia Bahia [UNIFESP]
Matarraz, Sergio
Chauffaille, Maria de Lourdes Lopes Ferrari [UNIFESP]
Lopez, Antonio
Orfao, Alberto
Yamamoto, Mihoko [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Univ Salamanca
Keywords: myelodysplastic syndromes
blast cell count
flow cytometry
Issue Date: 1-May-2013
Publisher: Wiley-Blackwell
Citation: Cytometry Part B-clinical Cytometry. Hoboken: Wiley-Blackwell, v. 84B, n. 3, p. 157-166, 2013.
Abstract: Background. Quantification of bone marrow (BM) blasts by cytomorphology is essential for the diagnosis of myelodysplastic syndromes (MDS). Owing to its subjectivity and the potential impact of dysplastic features on accurate identification of blast cells, more objective approaches are required, multiparameter flow cytometry (MFC) being a particularly promising approach in this regard. However, no consensus exists about the optimal combination of markers and strategy to be used. Methods. BM blast counts from 74 MDS patients were evaluated by morphology versus four different MFC phenotypic criteria: CD34+, CD34+ and/or CD117+, CD34+, and/or CD117+HLA-DR+, and CD34+ and CD117+HLA-DR+ plus CD64+CD14/lo cells. for each criterium, the percentage of blasts was calculated using either all BM nucleated cells or non-erythroid CD45+ cells as denominator. Results. the number of CD34+ and/or CD117+HLA-DR+cells showed the highest correlation and agreement with morphological counts, only a minor proportion of cases being misclassified by MFC vs. morphology for the >5% and >10% classification thresholds. in turn, a CD34+ phenotype was insufficient to correctly identify and quantify blasts. Conversely, usage of non-erythroid BM cells as denominator, or inclusion of CD34+ and/or CD117+HLA-DR+ plus CD64+CD14lo cells were both associated with overestimated blast counts. Conclusions. Quantification of CD34+ and/or CD117+HLA-DR+ cells (from all nucleated BM cells) by MFC is an efficient method for the enumeration of blasts in MDS. However, caution should be taken with replacing morphology by MFC blast counts; its combined use may rather provide complementary information increasing the accuracy and reproducibility of BM blast cell counts in these patients. (c) 2013 International Clinical Cytometry Society
ISSN: 1552-4949
Other Identifiers:
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.